US Stock MarketDetailed Quotes
VCYT Veracyte
- 19.900
- +0.070+0.35%
Close Apr 24 16:00 ET
1.49BMarket Cap-19509P/E (TTM)
20.070High19.660Low511.68KVolume19.850Open19.830Pre Close10.16MTurnover0.69%Turnover RatioLossP/E (Static)75.07MShares30.52052wk High1.43P/B1.48BFloat Cap18.61052wk Low--Dividend TTM74.51MShs Float86.030Historical High--Div YieldTTM2.07%Amplitude4.210Historical Low19.860Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Veracyte Stock Forum
ColumnsToday's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%,...
ColumnsToday's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
• $Theravance Biopharma(TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
ColumnsToday's pre-market stock movers: SE, AMD, WMT, JD and more
• $Microvast(MVST.US)$ +14.6% (In reaction to earnings)
• $Sea(SE.US)$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $JD.com(JD.US)$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase(COIN.US)$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen(HLGN.US)$ +5%(to restate Full Year 2021 Financials)
• $Take-Two Interactive Software(TTWO.US)$ +4.9% (de...
ColumnsToday's pre-market stock movers: TSLA, TWTR, AFRM, DWAC and more
• $Affirm Holdings(AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group(EDR.US)$ +20% (in reaction to earnings)
• $Coinbase(COIN.US)$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies(DVAX.US)$ +11.5% (to join ...
ARK's buys and sells (Dec.16)
ARK's buys
$Robinhood(HOOD.US)$$Nu Holdings(NU.US)$$Veracyte(VCYT.US)$$Personalis(PSNL.US)$$PagerDuty(PD.US)$$Quantum-Si(QSI.US)$
ARK's sells
$Iovance Biotherapeutics(IOVA.US)$$LivePerson(LPSN.US)$$3D Systems(DDD.US)$
Veracyte announced that it has begun rolling out its long-awaited nasal swab test for lung cancer at a limited number of clinical sites, as the company continues to accumulate data to support its future full commercial rollout.
The company also published recent findings showing that the Percepta Genomic test can more accurately group patients based on their risk of developing tumors and suspicious lung nodules.
No comment yet